Status:
UNKNOWN
Fibrotic Focus in Breast Cancer
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Despite the ongoing refinement of current breast cancer staging, clinical outcome is still varied among patients of similar stage. Further exploration of novel prognostic factors is of great clinical ...
Detailed Description
Background Breast cancers exhibit a wide scope of morphologic features with demonstrated prognostic significance. These features have the advantage of easily evaluated in routine reporting; thus offer...
Eligibility Criteria
Inclusion
- Patients with diagnosis of breast cancer who underwent surgical excisions with all tumor blocks available
Exclusion
- Patients who received neoadjuvant systemic treatment
Key Trial Info
Start Date :
December 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2023
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04122131
Start Date
December 1 2019
End Date
November 30 2023
Last Update
October 10 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.